Carl Christian Gilhuus

Biography

Dr. Gilhuus-Moe is Chairman of the Board of Oslo Medtech, a group of hospital, finance, knowledge and research institutions focusing on medical technology (medtech) innovation that facilitates development of medtech products and services. He is a Senior Advisor of NeoMed Management, a Europe-based venture capital fund focused on international healthcare and medical technology. Dr. Gilhuus-Moe is Chairman of the Board of Respinor AS and NeoRad AS, and a Board Member of Removaid AS. He was Chairman of the Board for both SINTEF-Unimed (the Norwegian Institute of Technology) and the European Committee for Clinical Laboratory Standardization (ECCLS). He was the founding President and CEO of Dynal Biotech AS (now part of Thermo Fisher Inc.). Prior to that position, Dr. Gilhuus-Moe was a member of the executive group, Vice President and head of Hafslund-Nycomed ASA's diagnostic division (now part of Abbott Laboratories). These executive and strategic positions and service on the board of directors of other companies have allowed him to develop expertise in the deployment of strategic growth initiatives within the industry and bring valuable, external insight to our board and organization. Dr. Gilhuus-Moe trained at the Swedish Institute of Management, the Sloan School of Management at the Massachusetts Institute of Technology and earned his doctorate in biochemistry from the University of Oslo.

Research Interest

 Hospital, Finance, Knowledge and Research Institutions Focusing on Medical Technology Innovation that facilitates development of Medtech Products and Services